Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
KEGG_2021_Human,Pathways in cancer,39/531,1.7453149251824237e-35,3.4208172533575504e-33,0,0,25.2203118752499,2018.470921058072,RB1;ITGB1;CDKN1A;HDAC1;KEAP1;ETS1;RXRA;CCND1;E2F1;ABL1;GNG8;AKT1;EP300;MAPK1;SKP2;RXRG;SMAD2;NCOA1;CREBBP;SMAD4;HSP90AA1;SMAD3;CHUK;CDKN2A;STAT1;ZBTB16;NCOA3;STAT3;ARNT;PML;NFKB1;NFKB2;NFKBIA;SP1;MDM2;RARA;CTNNB1;CALM1;PPARD
KEGG_2021_Human,Human T-cell leukemia virus 1 infection,23/219,2.957135093698496e-24,2.897992391824526e-22,0,0,30.0286244367877,1626.8854488001843,RB1;SMAD2;ATF2;CREBBP;SMAD4;CDKN1A;SMAD3;CHUK;CDKN2A;SRF;ETS1;NFKB1;ETS2;NFKB2;NFKBIA;KAT2B;CREB1;CCND1;KAT5;E2F1;AKT1;EP300;MAPK1
KEGG_2021_Human,Thyroid hormone signaling pathway,19/121,1.4429908121476526e-23,7.8395738228045e-22,0,0,45.52916969256839,2394.5037488302837,NCOA1;NCOA2;CREBBP;HDAC3;THRB;STAT1;SRC;HDAC1;NCOA3;KAT2B;RXRA;NCOR1;CCND1;MDM2;AKT1;CTNNB1;EP300;MAPK1;RXRG
KEGG_2021_Human,Viral carcinogenesis,22/203,1.5999130250621425e-23,7.8395738228045e-22,0,0,30.728006799830005,1612.8979547623344,RB1;HDAC4;ATF2;USP7;CREBBP;CDKN1A;HDAC3;CDKN2A;SRC;HDAC1;SRF;STAT3;NFKB1;NFKB2;NFKBIA;KAT2B;CREB1;CCND1;MDM2;EP300;MAPK1;SKP2
KEGG_2021_Human,Chronic myeloid leukemia,15/76,2.2598690353577274e-20,8.858686618602293e-19,0,0,57.39344262295082,2596.272440742808,RB1;CDKN1A;SMAD4;SMAD3;CHUK;HDAC1;CDKN2A;NFKB1;NFKBIA;CCND1;ABL1;E2F1;MDM2;AKT1;MAPK1
KEGG_2021_Human,Epstein-Barr virus infection,19/202,3.3113271494639484e-19,1.0817002021582229e-17,0,0,25.27308911826216,1075.41461738237,RB1;USP7;CDKN1A;CHUK;STAT1;HDAC1;STAT3;NFKB1;NFKB2;NFKBIA;NCOR2;PSMC5;CCND1;PSMD4;PSMD2;E2F1;MDM2;AKT1;SKP2
KEGG_2021_Human,Prostate cancer,15/97,1.1319554735238274e-18,3.095562400936309e-17,0,0,42.64992826398852,1762.4052871791555,RB1;CREBBP;CDKN1A;HSP90AA1;CHUK;NFKB1;NFKBIA;CREB1;CCND1;MDM2;E2F1;AKT1;EP300;MAPK1;CTNNB1
KEGG_2021_Human,Pancreatic cancer,14/76,1.263494857525024e-18,3.095562400936309e-17,0,0,52.08777194298575,2146.6751193706177,RB1;SMAD2;CDKN1A;SMAD4;SMAD3;CHUK;CDKN2A;STAT1;STAT3;NFKB1;CCND1;E2F1;AKT1;MAPK1
KEGG_2021_Human,Cellular senescence,17/156,2.2934223475979937e-18,4.994564223657853e-17,0,0,29.11822830891913,1182.680126926049,RB1;SMAD2;CDKN1A;SMAD3;CDKN2A;FOXO3;ETS1;SIRT1;NFKB1;CCND1;E2F1;MDM2;AKT1;MAPK1;NBN;CALM1;SQSTM1
KEGG_2021_Human,Human cytomegalovirus infection,19/225,2.5758141764473736e-18,5.0485957858368517e-17,0,0,22.425146829677573,908.2266543116394,RB1;ATF2;CDKN1A;CHUK;CDKN2A;SRC;STAT3;NFKB1;NFKBIA;CREB1;CCND1;SP1;E2F1;MDM2;GNG8;AKT1;CTNNB1;MAPK1;CALM1
KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,18/193,3.621873324679839e-18,6.453519742156802e-17,0,0,24.742160278745644,993.6337825487808,RB1;CREBBP;CDKN1A;CHUK;STAT1;SRC;STAT3;NFKB1;NFKBIA;CREB1;CCND1;E2F1;GNG8;AKT1;CTNNB1;EP300;MAPK1;CALM1
KEGG_2021_Human,Hepatitis B,17/162,4.404685294673347e-18,7.194319314633134e-17,0,0,27.90486082260075,1115.1860310364946,RB1;ATF2;CREBBP;SMAD4;CDKN1A;SMAD3;CHUK;STAT1;SRC;STAT3;NFKB1;NFKBIA;CREB1;E2F1;AKT1;EP300;MAPK1
KEGG_2021_Human,FoxO signaling pathway,15/131,1.2189317421248298e-16,1.837774011203589e-15,0,0,30.0973630831643,1102.8693121187298,USP7;CREBBP;SMAD4;CDKN1A;SMAD3;CHUK;STAT3;FOXO3;SIRT1;CCND1;MDM2;AKT1;EP300;MAPK1;SKP2
KEGG_2021_Human,Cell cycle,14/124,1.6481978645667833e-15,2.3074770103934967e-14,0,0,29.287526427061312,996.920862359748,RB1;SMAD2;CREBBP;SMAD4;CDKN1A;SMAD3;CDKN2A;HDAC1;CCND1;E2F1;MDM2;ABL1;EP300;SKP2
KEGG_2021_Human,Hepatitis C,15/157,1.9143595473705316e-15,2.5014298085641606e-14,0,0,24.55426677713339,832.1292032233323,RB1;CDKN1A;CHUK;STAT1;STAT3;NR1H3;NFKB1;PIAS1;NFKBIA;RXRA;CCND1;E2F1;AKT1;CTNNB1;MAPK1
KEGG_2021_Human,Th17 cell differentiation,13/107,6.710370029054985e-15,8.220203285592358e-14,0,0,31.484225972120324,1027.491565106429,SMAD2;SMAD4;HSP90AA1;SMAD3;CHUK;STAT1;STAT3;NFKB1;NFKBIA;RXRA;RARA;MAPK1;RXRG
KEGG_2021_Human,MicroRNAs in cancer,18/310,1.5871546566864957e-14,1.8298959571209009e-13,0,0,14.740394253257602,468.3649487069744,HDAC4;CREBBP;CDKN1A;UBE2I;CDKN2A;HDAC1;STAT3;SIRT1;THBS1;NFKB1;CCND1;E2F1;MDM2;ABL1;EP300;MAPK1;MDM4;TP63
KEGG_2021_Human,Small cell lung cancer,12/92,3.2260118046261306e-14,3.512768409481787e-13,0,0,33.78409090909091,1049.5009145808654,ITGB1;RB1;NFKBIA;CDKN1A;RXRA;CCND1;CHUK;E2F1;AKT1;SKP2;RXRG;NFKB1
KEGG_2021_Human,Chemical carcinogenesis,16/239,5.768414579038712e-14,5.950575039429408e-13,0,0,16.807174887892376,512.3464574888121,RB1;ATF2;HSP90AA1;SRC;STAT3;ARNT;NFKB1;RXRA;CREB1;KLF5;CCND1;E2F1;AKT1;MAPK1;PGR;RXRG
KEGG_2021_Human,Non-small cell lung cancer,11/72,6.515029237337817e-14,6.38472865259106e-13,0,0,40.19690550745994,1220.4616448380625,RB1;CDKN1A;RXRA;CCND1;CDKN2A;STAT3;E2F1;AKT1;MAPK1;FOXO3;RXRG
KEGG_2021_Human,Estrogen signaling pathway,13/137,1.7530664886147181e-13,1.636195389373737e-12,0,0,23.83092324805339,699.967589323808,NCOA1;ATF2;NCOA2;HSP90AA1;SRC;NCOA3;CREB1;SP1;RARA;AKT1;MAPK1;PGR;CALM1
KEGG_2021_Human,Bladder cancer,9/41,4.147701523242061e-13,3.695224993433835e-12,0,0,61.40521978021978,1750.727406729702,RB1;CDKN1A;CCND1;SRC;CDKN2A;E2F1;MDM2;MAPK1;THBS1
KEGG_2021_Human,Human papillomavirus infection,17/331,6.680051780371857e-13,5.69256586501254e-12,0,0,12.775765482311412,358.16194790126104,RB1;ITGB1;CREBBP;CDKN1A;CHUK;STAT1;HDAC1;THBS1;NFKB1;CREB1;CCND1;E2F1;MDM2;AKT1;CTNNB1;EP300;MAPK1
KEGG_2021_Human,Acute myeloid leukemia,10/67,1.2063417429570968e-12,9.85179090081629e-12,0,0,38.680311890838205,1061.5203810372304,CCND1;CHUK;ZBTB16;STAT3;RARA;AKT1;MAPK1;NFKB1;PML;PPARD
KEGG_2021_Human,Hepatocellular carcinoma,13/168,2.4495009786576955e-12,1.9204087672676328e-11,0,0,19.03485354097145,508.8994132773085,RB1;SMAD2;SMAD4;CDKN1A;SMAD3;CDKN2A;KEAP1;SMARCA4;CCND1;E2F1;AKT1;CTNNB1;MAPK1
KEGG_2021_Human,C-type lectin receptor signaling pathway,11/104,4.218044989419247e-12,3.17975699202374e-11,0,0,26.32318472876646,689.4476246616272,NFKBIA;CHUK;STAT1;SRC;BCL3;MDM2;AKT1;MAPK1;CALM1;NFKB1;NFKB2
KEGG_2021_Human,Breast cancer,12/147,9.521969586477185e-12,6.912244588701957e-11,0,0,19.964646464646464,506.6512064898509,RB1;NCOA1;CDKN1A;CCND1;SP1;NCOA3;E2F1;AKT1;CTNNB1;MAPK1;PGR;NFKB2
KEGG_2021_Human,Gastric cancer,12/149,1.1178143652058777e-11,7.824700556441144e-11,0,0,19.67120106171201,496.0498712906981,RB1;SMAD2;SMAD4;CDKN1A;RXRA;SMAD3;CCND1;E2F1;AKT1;CTNNB1;MAPK1;RXRG
KEGG_2021_Human,Cushing syndrome,12/155,1.78370085703886e-11,1.2055357516538503e-10,0,0,18.84011443102352,466.2880408228178,RB1;ATF2;NR4A1;CDKN1A;CREB1;CCND1;SP1;CDKN2A;E2F1;ARNT;CTNNB1;MAPK1
KEGG_2021_Human,PI3K-Akt signaling pathway,16/354,2.3148930868317324e-11,1.5123968167300648e-10,0,0,11.023950408565794,269.96632100405867,ITGB1;ATF2;HSP90AA1;CDKN1A;CHUK;FOXO3;THBS1;NFKB1;NR4A1;RXRA;CREB1;CCND1;MDM2;GNG8;AKT1;MAPK1
KEGG_2021_Human,Glioma,9/75,1.2933645263114394e-10,8.177401521194905e-10,0,0,29.72127872127872,676.7120240026644,RB1;CDKN1A;CCND1;CDKN2A;E2F1;MDM2;AKT1;MAPK1;CALM1
KEGG_2021_Human,Transcriptional misregulation in cancer,12/192,2.1809062683159127e-10,1.3358050893434967e-09,0,0,14.93939393939394,332.34340718536725,CDKN1A;RXRA;NCOR1;SP1;HDAC1;ZBTB16;MDM2;RARA;RXRG;RUNX2;PML;NFKB1
KEGG_2021_Human,Osteoclast differentiation,10/127,7.952928437188361e-10,4.622055993185714e-09,0,0,18.78727445394112,393.6368117947637,NFKBIA;JUND;CREB1;CHUK;STAT1;AKT1;MAPK1;SQSTM1;NFKB1;NFKB2
KEGG_2021_Human,Lipid and atherosclerosis,12/215,8.017852233077258e-10,4.622055993185714e-09,0,0,13.231303179579042,277.11879999630133,NFKBIA;HSP90AA1;RXRA;CHUK;HSPA4;SRC;STAT3;AKT1;MAPK1;CALM1;RXRG;NFKB1
KEGG_2021_Human,Apelin signaling pathway,10/137,1.673674428258207e-09,9.372576798245962e-09,0,0,17.299212598425196,349.58671561650493,SMAD2;HDAC4;SMAD4;SMAD3;CCND1;GNG8;AKT1;MAPK1;CALM1;PPARGC1A
KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,9/100,1.7678744766196074e-09,9.625094372706753e-09,0,0,21.52892162782273,433.8828609373099,SMAD2;SMAD4;SMAD3;CCND1;STAT1;STAT3;AKT1;MAPK1;NFKB1
KEGG_2021_Human,Adipocytokine signaling pathway,8/69,1.9109044962474524e-09,9.946536622018731e-09,0,0,28.280826799714895,567.7570877003315,NFKBIA;RXRA;CHUK;STAT3;AKT1;PPARGC1A;RXRG;NFKB1
KEGG_2021_Human,Fluid shear stress and atherosclerosis,10/139,1.928410161411795e-09,9.946536622018731e-09,0,0,17.02928509905254,341.7193401969315,HSP90AA1;CHUK;SUMO1;SRC;KEAP1;AKT1;CTNNB1;CALM1;SQSTM1;NFKB1
KEGG_2021_Human,Prolactin signaling pathway,8/70,2.148656494340398e-09,1.0798376227967131e-08,0,0,27.82328190743338,555.3088316848101,CCND1;SRC;STAT1;STAT3;AKT1;MAPK1;FOXO3;NFKB1
KEGG_2021_Human,Adherens junction,8/71,2.4116064830201007e-09,1.1816871766798494e-08,0,0,27.380262249827467,543.3057969185713,CREBBP;SMAD4;SMAD3;CSNK2A1;SRC;EP300;MAPK1;CTNNB1
KEGG_2021_Human,Melanoma,8/72,2.701970571248669e-09,1.291673736499364e-08,0,0,26.95108695652174,531.7256618513098,RB1;CDKN1A;CCND1;CDKN2A;E2F1;MDM2;AKT1;MAPK1
KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",9/106,2.977679850561884e-09,1.3895839302622124e-08,0,0,20.191118160190324,396.39448319138353,ATF2;CDKN1A;RXRA;JUND;CREB1;SP1;MAPK1;RXRG;RUNX2
KEGG_2021_Human,Proteoglycans in cancer,11/205,6.405578028678038e-09,2.9197518456299898e-08,0,0,12.554500173751885,236.8544137858684,SMAD2;ITGB1;CDKN1A;CCND1;SRC;STAT3;MDM2;AKT1;CTNNB1;MAPK1;THBS1
KEGG_2021_Human,JAK-STAT signaling pathway,10/162,8.512128274472943e-09,3.7917662313561294e-08,0,0,14.435672514619885,268.2404018173252,PIAS3;CREBBP;CDKN1A;CCND1;STAT1;STAT3;AKT1;EP300;PIAS2;PIAS1
KEGG_2021_Human,Colorectal cancer,8/86,1.1310854319550951e-08,4.926505436959969e-08,0,0,22.098104793756967,404.3401390457477,SMAD2;CDKN1A;SMAD4;SMAD3;CCND1;AKT1;MAPK1;CTNNB1
KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,8/89,1.4871345600954728e-08,6.336486386493756e-08,0,0,21.276435856146,383.48285414486656,NFKBIA;CHUK;CSNK2A1;STAT1;STAT3;AKT1;MAPK1;NFKB1
KEGG_2021_Human,Relaxin signaling pathway,9/129,1.690763071674106e-08,7.050841745704785e-08,0,0,16.302197802197803,291.73599373309673,SMAD2;NFKBIA;ATF2;CREB1;SRC;GNG8;AKT1;MAPK1;NFKB1
KEGG_2021_Human,TGF-beta signaling pathway,8/94,2.296427241845562e-08,9.334713571119265e-08,0,0,20.03437815975733,352.3912127034468,SMAD2;CREBBP;SMAD4;SMAD3;SP1;EP300;MAPK1;THBS1
KEGG_2021_Human,Tuberculosis,10/180,2.3336783927798164e-08,9.334713571119265e-08,0,0,12.895424836601308,226.6143312316135,CREBBP;CREB1;NFYA;STAT1;SRC;AKT1;EP300;MAPK1;CALM1;NFKB1
KEGG_2021_Human,Thyroid cancer,6/37,2.7527283964866817e-08,1.0790695314227793e-07,0,0,40.91077556623198,712.1783885669731,CDKN1A;RXRA;CCND1;MAPK1;CTNNB1;RXRG
KEGG_2021_Human,Measles,9/139,3.2447946300361784e-08,1.247019112719786e-07,0,0,15.040574809805578,259.35408721306123,NFKBIA;CCND1;CSNK2A1;CHUK;STAT1;STAT3;AKT1;NFKB1;TP73
KEGG_2021_Human,Ubiquitin mediated proteolysis,9/140,3.4535129609745994e-08,1.3017087314442721e-07,0,0,14.925006291418503,256.4308431573071,PIAS3;UBE2I;MDM2;KEAP1;STUB1;SKP2;PML;PIAS2;PIAS1
KEGG_2021_Human,Chemokine signaling pathway,10/192,4.304764295793659e-08,1.5891465834606669e-07,0,0,12.037851037851038,204.1734901828985,NFKBIA;CHUK;STAT1;SRC;STAT3;GNG8;AKT1;MAPK1;FOXO3;NFKB1
KEGG_2021_Human,Longevity regulating pathway,8/102,4.378260995248776e-08,1.5891465834606669e-07,0,0,18.321924144310824,310.44721644543296,ATF2;CREB1;HDAC1;AKT1;FOXO3;PPARGC1A;SIRT1;NFKB1
KEGG_2021_Human,Renal cell carcinoma,7/69,5.2866039801649644e-08,1.88395341838606e-07,0,0,24.083593479014915,403.5327631032912,CDKN1A;CREBBP;AKT1;EP300;ARNT;MAPK1;ETS1
KEGG_2021_Human,Glucagon signaling pathway,8/107,6.375766578633071e-08,2.231518302521575e-07,0,0,17.392182696530522,288.15675111469244,ATF2;CREBBP;CREB1;AKT1;EP300;CALM1;PPARGC1A;SIRT1
KEGG_2021_Human,Insulin resistance,8/108,6.857692673492913e-08,2.3580837964993178e-07,0,0,17.217391304347824,284.0062018560952,NFKBIA;CREB1;NR1H2;STAT3;AKT1;NR1H3;PPARGC1A;NFKB1
KEGG_2021_Human,HIF-1 signaling pathway,8/109,7.37063675498008e-08,2.4907669034070615e-07,0,0,17.046061127851914,279.9504729743466,CREBBP;CDKN1A;STAT3;AKT1;ARNT;EP300;MAPK1;NFKB1
KEGG_2021_Human,p53 signaling pathway,7/73,7.854858711367004e-08,2.6094106905558184e-07,0,0,22.61942000651678,370.0434977224353,CDKN1A;CCND1;CDKN2A;MDM2;MDM4;THBS1;TP73
KEGG_2021_Human,TNF signaling pathway,8/112,9.112417966875386e-08,2.927924461487829e-07,0,0,16.551839464882942,268.3225754833184,NFKBIA;ATF2;CREB1;CHUK;BCL3;AKT1;MAPK1;NFKB1
KEGG_2021_Human,Toxoplasmosis,8/112,9.112417966875386e-08,2.927924461487829e-07,0,0,16.551839464882942,268.3225754833184,NFKBIA;ITGB1;CHUK;STAT1;STAT3;AKT1;MAPK1;NFKB1
KEGG_2021_Human,"Growth hormone synthesis, secretion and action",8/119,1.4604827290263872e-07,4.543724045859872e-07,0,0,15.502546024285154,243.9996665332181,ATF2;CREBBP;CREB1;STAT1;STAT3;AKT1;EP300;MAPK1
KEGG_2021_Human,Neurotrophin signaling pathway,8/119,1.4604827290263872e-07,4.543724045859872e-07,0,0,15.502546024285154,243.9996665332181,NFKBIA;ABL1;AKT1;MAPK1;CALM1;FOXO3;NFKB1;TP73
KEGG_2021_Human,Influenza A,9/172,2.0294776140492868e-07,6.215275193025941e-07,0,0,11.975527539944718,184.5466783153094,NFKBIA;CREBBP;CHUK;STAT1;AKT1;EP300;MAPK1;PML;NFKB1
KEGG_2021_Human,Shigellosis,10/246,4.334728565260068e-07,1.3070873827553434e-06,0,0,9.258003766478344,135.64305575843323,NFKBIA;ITGB1;CHUK;SRC;MDM2;AKT1;MAPK1;FOXO3;SQSTM1;NFKB1
KEGG_2021_Human,Endometrial cancer,6/58,4.403792733101903e-07,1.3077929934666257e-06,0,0,24.363338788870703,356.57279981244113,CDKN1A;CCND1;AKT1;MAPK1;CTNNB1;FOXO3
KEGG_2021_Human,Mitophagy,6/68,1.1438701789268336e-06,3.346247090591932e-06,0,0,20.42347288949897,279.41543507643144,CSNK2A1;SRC;SP1;E2F1;FOXO3;SQSTM1
KEGG_2021_Human,Wnt signaling pathway,8/166,1.8512245124660932e-06,5.335882418284622e-06,0,0,10.865162355531096,143.41648413226528,CREBBP;SMAD4;SMAD3;CCND1;CSNK2A1;CTNNB1;EP300;PPARD
KEGG_2021_Human,AMPK signaling pathway,7/120,2.3686072852110697e-06,6.728217795672025e-06,0,0,13.180036159482349,170.7237553426521,CREB1;CCND1;HNF4A;AKT1;FOXO3;PPARGC1A;SIRT1
KEGG_2021_Human,Ras signaling pathway,9/232,2.4788659264179565e-06,6.940824593970277e-06,0,0,8.726802345636427,112.64302858240528,CHUK;ABL1;GNG8;AKT1;MAPK1;CALM1;ETS1;NFKB1;ETS2
KEGG_2021_Human,Alcoholism,8/186,4.317859229209183e-06,1.1919724069366196e-05,0,0,9.634587200781633,119.01365501541238,HDAC4;ATF2;CREB1;HDAC3;HDAC1;GNG8;MAPK1;CALM1
KEGG_2021_Human,Neutrophil extracellular trap formation,8/189,4.859546034356271e-06,1.3228764204636515e-05,0,0,9.473456641844823,115.90362610852726,HDAC4;FGA;HDAC3;SRC;HDAC1;AKT1;MAPK1;NFKB1
KEGG_2021_Human,Yersinia infection,7/137,5.714942831324485e-06,1.5344230067665742e-05,0,0,11.446650124069478,138.18883959303977,NFKBIA;ITGB1;CHUK;SRC;AKT1;MAPK1;NFKB1
KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,7/143,7.578986428271555e-06,1.976485039412849e-05,0,0,10.938330170777988,128.9643465517695,SMAD2;SMAD4;SMAD3;STAT3;AKT1;CTNNB1;MAPK1
KEGG_2021_Human,Spinocerebellar ataxia,7/143,7.578986428271555e-06,1.976485039412849e-05,0,0,10.938330170777988,128.9643465517695,PSMC5;PSMD4;KAT5;NFYA;SP1;PSMD2;AKT1
KEGG_2021_Human,IL-17 signaling pathway,6/94,7.663921581396761e-06,1.976485039412849e-05,0,0,14.370406189555126,169.26882409056034,NFKBIA;HSP90AA1;JUND;CHUK;MAPK1;NFKB1
KEGG_2021_Human,Notch signaling pathway,5/59,1.1418514477399644e-05,2.9065309578835457e-05,0,0,19.34307992202729,220.1295580852784,NCOR2;KAT2B;CREBBP;HDAC1;EP300
KEGG_2021_Human,Melanogenesis,6/101,1.1597918155781846e-05,2.914348664786208e-05,0,0,13.306830907054872,151.22794087889494,CREBBP;CREB1;CTNNB1;EP300;MAPK1;CALM1
KEGG_2021_Human,Chagas disease,6/102,1.2273346665327405e-05,3.0450328435495832e-05,0,0,13.16755319148936,148.8997525909875,SMAD2;NFKBIA;CHUK;AKT1;MAPK1;NFKB1
KEGG_2021_Human,cAMP signaling pathway,8/216,1.2906836561683136e-05,3.1621749576123686e-05,0,0,8.232441471571907,92.67879613941768,NFKBIA;CREBBP;CREB1;AKT1;EP300;MAPK1;CALM1;NFKB1
KEGG_2021_Human,NF-kappa B signaling pathway,6/104,1.371968195719744e-05,3.2793386141593875e-05,0,0,12.897524967433782,144.40944846252998,NFKBIA;UBE2I;CSNK2A1;CHUK;NFKB1;NFKB2
KEGG_2021_Human,Toll-like receptor signaling pathway,6/104,1.371968195719744e-05,3.2793386141593875e-05,0,0,12.897524967433782,144.40944846252998,NFKBIA;CHUK;STAT1;AKT1;MAPK1;NFKB1
KEGG_2021_Human,Alzheimer disease,10/369,1.6046293503991898e-05,3.789245212990858e-05,0,0,6.047972763850201,66.76981689647755,PSMC5;PSMD4;CSNK2A1;CHUK;PSMD2;AKT1;CTNNB1;MAPK1;CALM1;NFKB1
KEGG_2021_Human,MAPK signaling pathway,9/294,1.6749436856747346e-05,3.908201933241048e-05,0,0,6.806824754193175,74.85564507884291,ATF2;NR4A1;JUND;CHUK;SRF;AKT1;MAPK1;NFKB1;NFKB2
KEGG_2021_Human,Inflammatory bowel disease,5/65,1.8397859236857697e-05,4.242329894616598e-05,0,0,17.403508771929825,189.75526378900804,SMAD2;SMAD3;STAT1;STAT3;NFKB1
KEGG_2021_Human,cGMP-PKG signaling pathway,7/167,2.0814039417612187e-05,4.743664797502312e-05,0,0,9.286290322580646,100.10512157443648,ATF2;CREB1;SRF;AKT1;MAPK1;CALM1;GTF2I
KEGG_2021_Human,Huntington disease,9/306,2.296712195365504e-05,5.174202187260215e-05,0,0,6.527805527805528,69.72640775970387,PSMC5;CREBBP;CREB1;PSMD4;SP1;HDAC1;PSMD2;EP300;PPARGC1A
KEGG_2021_Human,Amphetamine addiction,5/69,2.464013413076116e-05,5.488029874578621e-05,0,0,16.3125,173.09412297852825,ATF2;CREB1;HDAC1;CALM1;SIRT1
KEGG_2021_Human,Leishmaniasis,5/77,4.1972173002737946e-05,9.243310009591727e-05,0,0,14.494152046783626,146.07936513066915,ITGB1;NFKBIA;STAT1;MAPK1;NFKB1
KEGG_2021_Human,B cell receptor signaling pathway,5/81,5.357670649553404e-05,0.00011667816081249632,0,0,13.728531855955678,135.0118210305148,NFKBIA;CHUK;AKT1;MAPK1;NFKB1
KEGG_2021_Human,Pathogenic Escherichia coli infection,7/197,5.9735336941349885e-05,0.0001286607257198305,0,0,7.808149405772496,75.93883482529385,NFKBIA;ITGB1;CHUK;SRC;ABL1;MAPK1;NFKB1
KEGG_2021_Human,ErbB signaling pathway,5/85,6.751700619952517e-05,0.000142891444441538,0,0,13.039473684210526,125.2197745880067,CDKN1A;SRC;ABL1;AKT1;MAPK1
KEGG_2021_Human,Focal adhesion,7/201,6.78005323115461e-05,0.000142891444441538,0,0,7.6456047001441085,73.38970469377347,ITGB1;CCND1;SRC;AKT1;CTNNB1;MAPK1;THBS1
KEGG_2021_Human,Rap1 signaling pathway,7/210,8.923304031073014e-05,0.0001860603819245012,0,0,7.303299962921764,68.09786172277165,ITGB1;SRC;AKT1;CTNNB1;MAPK1;CALM1;THBS1
KEGG_2021_Human,Human immunodeficiency virus 1 infection,7/212,9.467534608794754e-05,0.00019533018771829177,0,0,7.231313926042486,66.99853519369631,NFKBIA;CHUK;GNG8;AKT1;MAPK1;CALM1;NFKB1
KEGG_2021_Human,Th1 and Th2 cell differentiation,5/92,9.84688910332156e-05,0.00020104065252614847,0,0,11.986085904416212,110.5808703968905,NFKBIA;CHUK;STAT1;MAPK1;NFKB1
KEGG_2021_Human,Pathways of neurodegeneration,10/475,0.00013328867754934108,0.0002693255752543387,0,0,4.6439665471923535,41.43808226528781,PSMC5;VCP;PSMD4;CSNK2A1;PSMD2;CTNNB1;MAPK1;CALM1;SQSTM1;NFKB1
KEGG_2021_Human,Coronavirus disease,7/232,0.00016552619550618854,0.0003310523910123771,0,0,6.58183990442055,57.304006511979246,NFKBIA;FGA;CHUK;STAT1;STAT3;MAPK1;NFKB1
KEGG_2021_Human,Hippo signaling pathway,6/163,0.0001693432645465095,0.0003352654530415744,0,0,8.02669738446944,69.70049096231482,SMAD2;SMAD4;SMAD3;CCND1;CTNNB1;TP73
KEGG_2021_Human,T cell receptor signaling pathway,5/104,0.0001756383703175571,0.0003442512058224119,0,0,10.526847421584264,91.02652749721412,NFKBIA;CHUK;AKT1;MAPK1;NFKB1
KEGG_2021_Human,Legionellosis,4/57,0.00018964479109883465,0.0003680235550036791,0,0,15.602987421383649,133.7231842647315,NFKBIA;VCP;NFKB1;NFKB2
KEGG_2021_Human,Salmonella infection,7/249,0.000255072443694159,0.0004901392055299527,0,0,6.1141917710832665,50.58859624571247,NFKBIA;HSP90AA1;CHUK;AKT1;CTNNB1;MAPK1;NFKB1
KEGG_2021_Human,NOD-like receptor signaling pathway,6/181,0.0002981671128421135,0.0005673859623014975,0,0,7.194528875379939,58.40415261620702,NFKBIA;HSP90AA1;CHUK;STAT1;MAPK1;NFKB1
KEGG_2021_Human,Cortisol synthesis and secretion,4/65,0.0003152626587456224,0.0005941488568667498,0,0,13.55122950819672,109.25142744049542,ATF2;NR4A1;CREB1;SP1
KEGG_2021_Human,Long-term potentiation,4/67,0.0003541950453595573,0.0006611640846711736,0,0,13.119708994708995,104.244783981203,CREBBP;EP300;MAPK1;CALM1
KEGG_2021_Human,Platelet activation,5/124,0.000397478011409262,0.0007349593418510882,0,0,8.748783724015922,68.50622185570785,ITGB1;FGA;SRC;AKT1;MAPK1
KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,4/70,0.0004188784573037018,0.0007672913797338837,0,0,12.521464646464649,97.3910724894486,NFKBIA;CHUK;SRC;NFKB1
KEGG_2021_Human,Prion disease,7/273,0.0004440971794003297,0.000805954140393191,0,0,5.555744199207696,42.88738482268563,ATF2;PSMC5;CREB1;PSMD4;CSNK2A1;PSMD2;MAPK1
KEGG_2021_Human,PPAR signaling pathway,4/74,0.0005176957720029004,0.0009309024891061328,0,0,11.803571428571429,89.30727091866535,RXRA;NR1H3;RXRG;PPARD
KEGG_2021_Human,Dopaminergic synapse,5/132,0.0005291724539621734,0.0009428890997871452,0,0,8.194363862411935,61.81988854263416,ATF2;CREB1;GNG8;AKT1;CALM1
KEGG_2021_Human,Pertussis,4/76,0.0005728566057742373,0.0010115305831689,0,0,11.474537037037036,85.65598609029966,ITGB1;MAPK1;CALM1;NFKB1
KEGG_2021_Human,Antigen processing and presentation,4/78,0.0006320694999065338,0.0011061216248364,0,0,11.163288288288287,82.23448822300136,HSP90AA1;CREB1;NFYA;HSPA4
KEGG_2021_Human,Apoptosis,5/142,0.0007370346891140768,0.0012783964519146,0,0,7.592393392239724,54.762989036023214,NFKBIA;CHUK;AKT1;MAPK1;NFKB1
KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,5/150,0.000943057893910248,0.0016213977825123,0,0,7.170598911070781,49.95313752128969,ATF2;CREB1;AKT1;MAPK1;CALM1
KEGG_2021_Human,Oxytocin signaling pathway,5/154,0.0010608199151585,0.0018080061162702,0,0,6.97668668315083,47.78132593492158,CDKN1A;CCND1;SRC;MAPK1;CALM1
KEGG_2021_Human,Circadian entrainment,4/97,0.0014281711993084,0.002413116854004,0,0,8.87410394265233,58.13745435142573,CREB1;GNG8;MAPK1;CALM1
KEGG_2021_Human,Aldosterone synthesis and secretion,4/98,0.0014832934752283,0.0024848335140577,0,0,8.779255319148936,57.18359473531712,ATF2;NR4A1;CREB1;CALM1
KEGG_2021_Human,Proteasome,3/46,0.0015751859953084,0.0026164106362751,0,0,14.282186526012946,92.16840432528492,PSMC5;PSMD4;PSMD2
KEGG_2021_Human,Progesterone-mediated oocyte maturation,4/100,0.0015979577835658,0.0026319304670495,0,0,8.59548611111111,55.34658305163635,HSP90AA1;AKT1;MAPK1;PGR
KEGG_2021_Human,Cocaine addiction,3/49,0.0018912091143729,0.0030889748868091,0,0,13.348722545943524,83.70368414188104,ATF2;CREB1;NFKB1
KEGG_2021_Human,Cholinergic synapse,4/113,0.0024974828876877,0.0040455094709652,0,0,7.565366972477064,45.33524899002028,CREB1;GNG8;AKT1;MAPK1
KEGG_2021_Human,VEGF signaling pathway,3/59,0.0032188419242375,0.0051712542389389,0,0,10.959499263622977,62.89364704662167,SRC;AKT1;MAPK1
KEGG_2021_Human,Diabetic cardiomyopathy,5/203,0.0035416739735841,0.0056436430798576,0,0,5.237107921318447,29.55381588753612,SMAD2;SMAD3;SP1;AKT1;NFKB1
KEGG_2021_Human,Cytosolic DNA-sensing pathway,3/63,0.0038757213407073,0.0061261401836987,0,0,10.22680412371134,56.78968343517464,NFKBIA;CHUK;NFKB1
KEGG_2021_Human,Insulin signaling pathway,4/137,0.0049739964840798,0.0077992264870372,0,0,6.192669172932331,32.84301689755327,AKT1;MAPK1;CALM1;PPARGC1A
KEGG_2021_Human,RIG-I-like receptor signaling pathway,3/70,0.0052097235794995,0.0081040144569993,0,0,9.155100784736112,48.13045658628783,NFKBIA;CHUK;NFKB1
KEGG_2021_Human,Bacterial invasion of epithelial cells,3/77,0.0067890554235683,0.0104775973466094,0,0,8.286152131512956,41.36814601724816,ITGB1;SRC;CTNNB1
KEGG_2021_Human,mTOR signaling pathway,4/154,0.0074843681189679,0.0114604386821697,0,0,5.486111111111111,26.85417750424261,CHUK;AKT1;MAPK1;SKP2
KEGG_2021_Human,Non-alcoholic fatty liver disease,4/155,0.0076537056916765,0.0116288861671985,0,0,5.449503311258278,26.553060978024,RXRA;AKT1;NR1H3;NFKB1
KEGG_2021_Human,Necroptosis,4/159,0.0083562740420879,0.0125986900942249,0,0,5.307795698924731,25.396436404946197,HSP90AA1;STAT1;STAT3;SQSTM1
KEGG_2021_Human,Endocytosis,5/252,0.0087117104640192,0.0130343148927311,0,0,4.1877264010228,19.86275118853376,SMAD2;SMAD3;SRC;MDM2;PML
KEGG_2021_Human,Tight junction,4/169,0.0102942937098221,0.0152854664176147,0,0,4.983585858585859,22.80571390169924,ITGB1;CCND1;HSPA4;SRC
KEGG_2021_Human,GnRH signaling pathway,3/93,0.0113729262286274,0.0167601018106088,0,0,6.8075601374570445,30.474176658100003,SRC;MAPK1;CALM1
KEGG_2021_Human,Herpes simplex virus 1 infection,7/498,0.0124937604410941,0.0182744555705556,0,0,2.97534108578061,13.03950944120715,NFKBIA;CHUK;STAT1;SRC;AKT1;PML;NFKB1
KEGG_2021_Human,Choline metabolism in cancer,3/98,0.0130939766052085,0.0190105141823768,0,0,6.447639717851329,27.954405817650997,SP1;AKT1;MAPK1
KEGG_2021_Human,Axon guidance,4/182,0.0132197339935216,0.0190519695788988,0,0,4.616573033707865,19.97150068730587,ITGB1;SRC;ABL1;MAPK1
KEGG_2021_Human,Aldosterone-regulated sodium reabsorption,2/37,0.0147110875878218,0.0210465194687086,0,0,11.583090379008746,48.87083992538764,MAPK1;NR3C2
KEGG_2021_Human,Sphingolipid signaling pathway,3/119,0.0218742991047355,0.0310678451052765,0,0,5.274795591894774,20.16260489683167,AKT1;MAPK1;NFKB1
KEGG_2021_Human,Oocyte meiosis,3/129,0.0269470472113718,0.0379972752045243,0,0,4.853706431026018,17.540720135105115,MAPK1;PGR;CALM1
KEGG_2021_Human,Thermogenesis,4/232,0.0291582650142166,0.0408215710199033,0,0,3.595029239766082,12.708489019482474,ATF2;CREB1;PPARGC1A;SMARCA4
KEGG_2021_Human,Autophagy,3/137,0.0314194441411021,0.0436752556855037,0,0,4.562086474842284,15.786317107275496,AKT1;MAPK1;SQSTM1
KEGG_2021_Human,Amyotrophic lateral sclerosis,5/364,0.0359938548286516,0.0495222069845743,0,0,2.864829203929043,9.52385841490898,PSMC5;VCP;PSMD4;PSMD2;SQSTM1
KEGG_2021_Human,Viral myocarditis,2/60,0.0363103684614095,0.0495222069845743,0,0,6.9817030260380015,23.148897224333663,CCND1;ABL1
KEGG_2021_Human,Parkinson disease,4/249,0.0363836622743811,0.0495222069845743,0,0,3.342687074829932,11.07644636839962,PSMC5;PSMD4;PSMD2;CALM1
